《半日总结》港股升21点 医药股急涨 百威亚太跌5%
美联储维持现有量宽计划，美股个别发展，道指跌44点0.2%，纳指破顶。港股在内地股市带动下造好。恒指高开252点报26,408点，但已为半日高位，其後升幅收窄，并曾倒跌69点见26,390点。半日升21点或0.1%，报26,481点；国指升28点或0.3%，报10,490点；恒生科技指数升75点或0.9%，报8,221点。大市半日总成交额656.07亿元，沪、深港通南下交易半日录得净流入金额分别为5.76亿及6.52亿元人民币。
科技股普遍上升，腾讯(00700.HK)升0.9%报576.5元，阿里巴巴(09988.HK)升2.1%报256.2元，小米(01810.HK)平收报29.3元，美团(03690.HK)升1.4%报283.2元，京东(09618.HK)及网易(09999.HK)各升3.4%及4.1%。平安好医生(01833.HK)、众安在线(06060.HK)及祖龙娱乐(09990.HK)各升2.1%至2.6%，金蝶(00268.HK)及微盟(02013.HK)各升4.5%及5.3%。心动(02400.HK)跌2.3%。
手机相关股丘钛(01478.HK)及鸿腾(06088.HK)各跌2.7%及4.1%。晶片相关股ASM太平洋(00522.HK)升3.3%，中芯(00981.HK)跌2.1%报19.78元。电讯股中移动(00941.HK)跌0.8%报44.05元，中国铁塔(00788.HK)升1.7%。
金融股普遍向下，汇控(00005.HK)跌0.8%报40.95元，港交所(00388.HK)升0.5%报389.2元，友邦(01299.HK)跌1.5%报89.6元。内银股招行(03968.HK)跌2.4%，建行(00939.HK)、工行(01398.HK)及中行(03988.HK)各跌0.7%至0.9%，内险股中国平安(02318.HK)升0.8%报94.45元。
医药股造好，中生制药(01177.HK)、信达生物(01801.HK)及绿叶制药(02186.HK)各升5.4%至5.9%，石药(01093.HK)及药明生物(02269.HK)各升4%及4.8%，国药(01099.HK)、复星医药(02196.HK)及翰森制药(03692.HK)各升2.2%至2.3%。内需股方面，维他奶(00345.HK)及恒安(01044.HK)各升2.4%及3.6%，国美(00493.HK)升5.4%。百威亚太(01876.HK)遭券商唱淡，股价跌5%。
建材及基建股上升，海螺水泥(00914.HK)、中铁建(01186.HK)及中交建(01800.HK)各升2.5%至3.1%，中建材(03323.HK)升3.9%。钢铁股马钢(00323.HK)、鞍钢(00347.HK)及重庆钢铁(01053.HK)各升逾2%。资源股见追捧，中铝(02600.HK)、洛钼(03993.HK)、江铜(00358.HK)及五矿资源(01208.HK)各升4.5%至5.5%。油服股个别发展，海隆(01623.HK)及安东油服(03337.HK)各跌逾3%，中海油服(02883.HK)升4.5%。油股中海油(00883.HK)升1.3%，天然气股昆仑能源(00135.HK)升3.9%。
其他股份方面，创科(00669.HK)升2.2%。新股远洋服务(06677.HK)半日收5.65元，较上市价5.88元跌3.9%。云想科技(02131.HK)半日收8.05元，较上市价6.98元升15.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
